506O Evaluation of risk of disease progression in first-line therapy of unresected metastatic colorectal cancer to guide intervals of radiological assessment: An analysis of eleven randomized trials by AIO and GONO.

Saved in:
Bibliographic Details
Title: 506O Evaluation of risk of disease progression in first-line therapy of unresected metastatic colorectal cancer to guide intervals of radiological assessment: An analysis of eleven randomized trials by AIO and GONO.
Authors: Germani, M.M.1 (AUTHOR), Heinemann, V.2 (AUTHOR), Rossini, D.3 (AUTHOR), Fischer von Weikersthal, L.4 (AUTHOR), Morano, F.5 (AUTHOR), Heinrich, K.6 (AUTHOR), Stahler, A.7 (AUTHOR), Bergamo, F.8 (AUTHOR), Kaiser, F.9 (AUTHOR), Decker, T.10 (AUTHOR), Salvatore, L.11 (AUTHOR), Weiss, L.12 (AUTHOR), Russo, A.5 (AUTHOR), Fuchs, M.13 (AUTHOR), Prete, A.A.14 (AUTHOR), Antoniotti, C.15 (AUTHOR), Masi, G.16 (AUTHOR), Stintzing, S.17 (AUTHOR), Cremolini, C.16 (AUTHOR), Modest, D.P.7 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS430-S431. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2024.08.575